Evidence map›Paper›PMID 19076372›Full record

ReviewAnnals of the New York Academy of Sciences2008

Neuropeptides, mesenteric fat, and intestinal inflammation.

Iordanes Karagiannides, Charalabos Pothoulakis

Open access · greenAbstract readReview
In one paragraph

Review in Annals of the New York Academy of Sciences, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Sex hormones in the modulation of irritable bowel syndrome.World journal of gastroenterology · 2014
    Review
  7. Article
  8. Review
  9. Sex difference in irritable bowel syndrome: do gonadal hormones play a role?Gastroenterologia Polska : organ Polskiego Towarzystwa Gastroenterologii · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Iordanes KaragiannidesInflammatory Bowel Disease Center, Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-7019, USA.
Charalabos Pothoulakis
University of California, Los Angeles · US

Funding

Xenograft and Isograft CoreP01DK033506 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI MCCORMICK, BETH A · 1986 to 2015
$24.2M
Mechanisms of Neurotensin in Intestinal InflammationR01DK060729 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI POTHOULAKIS, CHARALABOS · 2002 to 2017
$5.0M
Toll-like receptors and intestinal inflammationR01DK072417 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI POTHOULAKIS, CHARALABOS · 2006 to 2010
$1.5M
NIDDK NIH HHS P01 DK033506NIDDK NIH HHS P01 DK 33506NIDDK NIH HHS R01 DK060729NIDDK NIH HHS R01 DK072417NIDDK NIH HHS R01 DK072471NIDDK NIH HHS R01 DK60729
6 · The paper itself

Abstract

The ability of fat tissue cells to produce proinflammatory cytokines and the concept that obesity represents a low-grade inflammatory response have been well documented during the past decade. The effects of fat-mediated inflammation on metabolic pathologies have also been drawing increasing interest. However, very little is known on the potential effects of adipose tissue in the pathophysiology of gastrointestinal diseases with an inflammatory component, such as inflammatory bowel disease (IBD). The development of large fat masses around the inflamed intestine during Crohn's disease makes this tissue a candidate for more intense investigation in studies aiming to gain insights into the pathogenesis and progress of the disease. Furthermore, neuropeptides act in many cases in a proinflammatory manner and are shown to participate in the pathogenesis of intestinal inflammation in animal models of IBD. However, the potential of these molecules to interact with fat cells in the context of IBD has not been investigated. In this review the authors' most recent data related to the effects of neuropeptides on noninflammatory fat tissue components are described. In addition, a discussion to associate neuropeptide-induced, adipose tissue-mediated responses with the generation of intestinal inflammatory conditions such as Crohn's disease is included.

Indexed as

Adipose TissueAnimalsHumansHypothalamic HormonesInflammatory Bowel DiseasesIntestinal MucosaIntestinesMelaninsMesenteryMiceModels, BiologicalNeuropeptidesNeurotensinPituitary HormonesHypothalamic Hormonesmelanin-concentrating hormoneMelaninsNeuropeptidesNeurotensinPituitary Hormones

Identifiers

PMID19076372
PMCPMC4404029
OpenAlexW2061101530

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.